Mitralign raises $10m

Share this story

Mitralign raises $10m

Mitralign, which is looking to commercialize its namesake mitral valve treatment and pursue regulatory nods for its Trialign tricuspid valve device, said it raised nearly $10 million.

The $9.8 million funding, of a hoped-for $30.2 million, came from 19 unnamed investors beginning last September, the Tewksbury, Mass.-based company said in a regulatory filing. Mitralign raised a $40 million Series E round in May 2016.

See full article by Brad Perriello of MassDevice here

Leave a Comment

Your email address will not be published. Required fields are marked *